Sapanisertib, Carboplatin, and Paclitaxel in Treating Patients With Recurrent or Refractory Malignant Solid Tumors

NCT03430882 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Malignant Solid Neoplasm
Refractory Malignant Solid Neoplasm

Interventions

DRUG: Carboplatin
DRUG: Paclitaxel
DRUG: Sapanisertib

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]